Document Classification

Section Type: RESULTS

Text: PIO 30 treated patients had similar increase in plasma 15-epi-LXA (4) (0. 64 0. 10-1. 08 0. 09 ng/mL, p < 0. 01), and decrease in plasma FFA (423 42-317 40 mol/l, p < 0. 05) despite a greater increase in plasma adiponectin (6. 5 0. 4-15. 5 0. 7 ug/mL, p < 0. 001) and a greater reduction in HbA1c (8. 7 0. 5-7. 4 0. 3 %, p < 0. 01), FPG (159 16-120 10 mg/dL, p < 0. 01), and HOMA-IR (6. 6 0. 8-4. 4 0. 4, p < 0. 005).